Learn about our journey
We aim to empower individuals to achieve their personal and professional.
GenePrint Labs is committed to advancing the frontiers of genomic science by delivering cutting-edge solutions to the scientific and clinical communities. Established in 2018 by Mr. Ashish Dubey with a vision to drive precision medicine, GenePrint Labs provides a comprehensive suite of Next-Generation Sequencing (NGS) and Microarray services supporting oncogenomics, pharmacogenomics, personalized genomics, and genomics research.
With a leadership team and scientific experts bringing over two decades of experience in advanced genomics technologies, we specialize in translating complex genomic data into meaningful insights. Our core strengths include a highly skilled Bio-IT division, an agile research and development team, and an unwavering commitment to scientific rigor and innovation.
From developing custom oncology panels for cancer research to enabling clinicians with pharmacogenomic interpretations, and empowering wellness brands with gut microbiome and trait-based genomic solutions—GenePrint Labs operates at the intersection of science, data, and personalized healthcare.
We proudly collaborate with academic institutions, hospitals, contract research organizations (CROs), and biotech companies, offering end-to-end solutions—from sample processing and sequencing to bioinformatics analysis and clinical-grade reporting—with an emphasis on quality, speed, and scientific impact.
Our Mission
At GenePrint Labs, our mission is to deliver high-quality, accessible, and clinically impactful genomic solutions by offering:
- Single-gene and multi-gene panels for cancer diagnostics and inborn errors of metabolism (IEM),
- Personalized genomics and pharmacogenomics to support tailored healthcare decisions,
- Gut microbiome profiling using both V3–V4 and V1–V9 16S rRNA regions for research and wellness,
- A full spectrum of routine NGS services for research and clinical applications on various platforms such as Illumina, Nanopore and PacBio,
- And the development of cost-effective oncology NGS panels focused on screening hotspot regions critical to early cancer detection.
Through innovation, scientific rigor, and a patient-centred approach, we aim to empower clinicians, researchers, and wellness providers with genomics-driven insights that transform healthcare outcomes.
Our Vision
To become a leading precision genomics company driving healthcare transformation through integrated multi-omics and Bio-IT platforms.
Schedule a free consultation with one of our experts.
At Geneprint, we offer free, no-obligation consultations to help you plan the right strategy for your RNA or DNA-based study. Whether you’re an academic researcher, clinician, or biotech professional, our team is here to understand your goals and recommend the best solutions